メリムスキー教授は、スラスキー医療センターの軟部組織・骨腫瘍科を率いており、肺がん治療において数十年の専門知識を有しています。
ハジェテペ大学がん研究所およびMDアンダーソンがんセンターで研修を受けた、肺がん外科の専門医。
Teknonメディカルセンターの呼吸器科部長。32 年の経験を持ち、複雑な肺疾患を専門とする。
准教授のタフシン・オザトリは、Istinye Liv大学病院で肺がん治療を専門としており、腫瘍学において豊富な経験を持っています。
ジェーン・ドウ医師は、クリーブランド・クリニックで低侵襲ロボット手術を専門としています。
ドブリトイウ医師は、Ponderasアカデミック病院にて低侵襲胸部外科を専門としており、ロボット支援およびVATS技術を用いて早期回復を実現しています。
アレムダル医師は、腫瘍学および内科における広範なトレーニングと経験を活かし、肺全摘術を専門としています。
エセル医師は胸部外科を専門とし、メディカルパーク・アンタルヤ病院コンプレックスにて肺全摘術の豊富な経験を有しています。
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.
イ・ナグォン医師は、呼吸器内科医および集中治療専門医です。ナウン病院の呼吸器内科の最高医療責任者を務めています。専門分野は、肺炎、肺結核、慢性咳嗽、慢性肺疾患、アレルギー性鼻炎、喘息、および呼吸器集中治療です。
延世大学で医学博士号および医学修士号を取得。延世大学原州セブランスキリスト教病院にてインターンシップ、内科レジデント、呼吸器内科フェローシップを修了。延世大学原州医科大学の非常勤教授を務めた経験があります。また、嘉泉大学医学部および仁荷大学医学部で臨床教授も務めました。大韓内科学会および大韓結核・呼吸器学会の正会員です。著書に「肺結節の経気管支肺生検の診断収率に対する気管支鏡径の影響」があります。
クルト・ラッシェ医師は、ヴッパータールにあるヘリオス大学病院の呼吸器内科部長です。認定肺がんセンターおよび睡眠医学部門を統括しています。数十年にわたる臨床経験を持ち、慢性肺疾患および呼吸障害に注力しています。ラッシェ医師は、年間15万人が受診する病院で患者の治療にあたっています。
Yildiray Bekar医師は、イスタンブールのMedical Park Bahcelievler病院の胸部外科医です。肺がんおよび肺気腫の外科的治療を専門としています。Bekar医師は、開胸手術と低侵襲手術の両方の技術を駆使します。肺、食道、胸壁の複雑な疾患に焦点を当てています。
准教授のジェヴペル・エルソズは、メディポル・アジバデム地区病院にて泌尿器がんおよび低侵襲治療を専門としています。
イリアズ教授は肺がんおよび胸部疾患を専門とし、豊富な学術的・臨床的経験を有しています。
ボルデ医師は、HCG Manavataがんセンターにて30,000件以上のPET検査と1,000人の甲状腺がん患者の治療を担当してきました。
ディラヴェル・タシュ博士は、イスタンブールのバシュケント大学病院の肺疾患教授です。呼吸器内科および内科において30年以上の経験を有しています。タシュ博士は以前、主要な軍病院で医長を務めていました。肺がん、COPD、結核などの複雑な疾患の治療を専門としています。
当医師は、複雑な呼吸器疾患の診断と管理において豊富な専門知識を持つ、高度に専門化された呼吸器内科医です。臨床的な重点分野には、慢性閉塞性肺疾患（COPD）、喘息、間質性肺疾患、サルコイドーシス、肺高血圧症、肺がんが含まれます。当医師は、気管支鏡検査、胸腔穿刺、胸水ドレナージを含む高度な診断および治療手技に精通しています。
さらに、集中治療室でのモニタリング、非侵襲的および侵襲的機械換気、呼吸リハビリテーションを必要とする患者に対して包括的なケアを提供します。その他の臨床能力には、睡眠時無呼吸症候群の管理、肺塞栓症の治療、および専門的な禁煙プログラムが含まれます。
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 41年の経験 | 複雑な胸部腫瘍学の症例 | イスラエルを代表する軟部組織・骨腫瘍科の責任者。ギュスターヴ・ルシー研究所で肉腫の専門知識を習得したESMOの教員。 | イスラエル | から $950 | |
| #2 | 20年の経験 | 肺がん外科手術 | 肺がん専門医。ハジェテペ大学で腫瘍学のフェローシップを取得し、MDアンダーソンがんセンターで研修を受けた、複雑な症例のスペシャリスト。 | トルコ | から $100 | |
| #3 | 32年の経験 | 複雑な肺疾患 | バルセロナの主要病院で呼吸器科を率いる。COPDのバイオマーカーおよび肺疾患における筋肉の変化に関する研究で実績がある。 | スペイン | お問い合わせください | |
| #4 | 2016年の経験 | 肺がん治療 | 包括的な腫瘍ケアに重点を置いた肺がんの専門家。トルコの主要病院での経験を持つ准教授。 | トルコ | お問い合わせください | |
| #5 | 40年の経験 | 複雑な症例や再手術が必要な症例 | ダビンチ（da Vinci）システムにおける15年の経験 | 中国 | お問い合わせください | |
| #6 | 11年の経験 | 低侵襲肺全摘術 | ロボット支援および単孔式VATS技術を用いて、より低侵襲な肺切除を行います。Ponderasアカデミック病院にて、術後ドレナージ不要のケアを専門としています。 | ルーマニア | お問い合わせください | |
| #7 | 20年の経験 | 肺がん症例 | 肺がん治療に重点を置いた腫瘍内科を専門としています。主要な大学医療センターで研修を受けた認定専門医です。 | トルコ | お問い合わせください | |
| #8 | 15年の経験 | 複雑な胸部症例 | 肺全摘術の豊富な経験を持つ胸部外科専門医。アクデニズ大学病院で研修を受け、ハラン大学で勤務。 | トルコ | お問い合わせください | |
| #9 | 20年の経験 | ロボット泌尿器科手術 | 泌尿器がんの低侵襲治療を専門とする。欧州泌尿器科学会会員であり、広範な研究出版物を持つ。 | トルコ | お問い合わせください | |
| #10 | 19年の経験 | 肺がんおよび胸部外科 | 肺がんを専門とし、強力な研究背景を持つ。胸部医学における受賞歴のある多数の論文を執筆。主要な呼吸器学会の会員。 | トルコ | お問い合わせください |